期刊文献+

不同心律的慢性充血性心力衰竭患者对美托洛尔的耐受性比较 被引量:4

A comparison of tolerance of metoprolol in chronic congestive heart failure patients with different cardiac rhythm
原文传递
导出
摘要 目的 :比较不同心律状态下的慢性充血性心力衰竭 (CHF)患者对美托洛尔治疗的剂量耐受情况。方法 :对 14 6例CHF患者 [其中窦性心律 (窦律 ) 10 3例、心房颤动 (房颤 )心律 2 8例、起搏器心律 15例 ]在常规心力衰竭 (心衰 )治疗基础上口服美托洛尔 ,逐渐加量至目标剂量。治疗目标分别为 :①心室率下降到 5 0~ 6 5次 /min(不低于 5 0次 /min) ;②稍加剂量心功能下降 1级 ;③收缩压不低于 90mmHg(1mmHg =0 .133kPa) ;④达最大剂量 :2 0 0mg/d。结果 :窦律者美托洛尔平均剂量低于房颤和起搏器心律者 [(72 .7± 36 .1)mg/d∶(10 4 .7±2 8.7)mg/d和 (10 8.7± 2 4 .6 )mg/d ,P <0 .0 1];窦律者达心率目标的平均剂量低于达心衰的目标剂量 ,房颤者心率和心衰的目标剂量相当 ,而 3种不同心律患者达心衰目标剂量无明显差异 (P >0 .0 5 )。结论 :不同心律的CHF患者对美托洛尔的耐受性均较好 。 Objective:To compare the tolerance of Metoprolol in congestive heart failure (CHF) patients with different cardiac rhythm.Methods:Metorolol was orally administealed in CHF patients [103 with sinus rhythm, 28 with atrial fibrillation (AF) rhythm and 15 with cardiac pacing rhythm] at the basis of regular regimen and the dosage was increasingly added to the target dose. The target doses were respectively defined as: ① heart rate to 50~65 bpm (no less than 50bpm); ② cardiac function worsen to next degree with dosage adding; ③ systolic blood pressure no less than 90mmHg; ④ to the defined dose of (200 mg/day). Results:The average dose of Metoprolol was lower in patients with sinus rhythm than in patients with AF rhythm and cardiac pacing rhythm ( 72.7 ± 36.1 ) mg/d vs ( 104.7 ± 28.7 ) mg/d and ( 108.7 ± 24.6 ) mg/d, P< 0.01 ). The average dose to heart rate target was less than to heart failure target in patients with sinus rhythm and was almost the same in patients with AF rhythm. There was no significant difference in average doss to heart failure target among all patients with different rhythm. Conclusion:The good tolerance to Metoprolol was found in CHF patients with different cardiac rhythm and was better in patients with AF and cardiac pacing rhythm than with sinus one.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2003年第2期100-102,共3页 Journal of Clinical Cardiology
关键词 心力衰竭 充血性 美托洛尔 心律 Congestive heart failure Metoprolol
  • 相关文献

参考文献8

  • 1慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2413
  • 2[2]CIBIS-ⅡInvestigators and Committees. The cardiac insufficiency bisoprolol study Ⅱ(CIBIS-Ⅱ). Lancet, 1999,353:9-13.
  • 3[3]MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure(MERIT-HF). Lancet, 1999,353:2001-2007.
  • 4[4]Packer M, Bristow M R, Cohn J N, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure, N Engl J Med, 1996,334: 1340-1355.
  • 5[5]Packer M, Coats A J S, Fowler M B, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344: 1651-1658.
  • 6[6]Bristow M R, Gilbert E M, Abraham W T, et al. Multicenter oral carvedilol heart failure assessment. Circulation,l996,94:2807-2816.
  • 7[7]Brat B A, Ertl G, Held P, et al. Contemporary management of patients with left ventricular systolic dysfunction: Results from the SPICE registry. Eur Heart J, 1999,20:1182-1190.
  • 8上海市心力衰竭调查协作组.上海市1980、1990、2000年心力衰竭住院患者流行病学及治疗状况调查[J].中华心血管病杂志,2002,30(1):24-27. 被引量:195

二级参考文献13

  • 1Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
  • 2Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
  • 3Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
  • 4Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
  • 5Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
  • 6Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
  • 7Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
  • 8Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
  • 9Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.
  • 10The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomised trial. Lancet, 1999,353:9-13.

共引文献2580

同被引文献16

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部